Neoplasms, Hormone-Dependent: Clinical Trials

7 trials for Neoplasms, Hormone-Dependent, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 2 terminated, 1 unknown. 3 Phase 3, 2 Not applicable, 1 Phase 2, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 33Terminated 2, Completed 1
Not applicable2Completed 2
Phase 21Completed 1
Phase 41Unknown 1

Follow Neoplasms, Hormone-Dependent: new trials by email Literature Review of Neoplasms, Hormone-Dependent trials Research Report on Neoplasms, Hormone-Dependent

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Research Study for Latina Women With Breast Cancer
"My Guide" (psychoeducation & self-management program) - Cancer, Breast, Cancer-related Problem/Condition
Not applicableCompletedNorthwestern University582021-04-012023-11-08
A Web-Based Tool to Improve Breast Cancer Survivorship
"OncoTool" Intervention (MBSR + HT education), "Oncotool" Control (health +HT education) - Breast Cancer, Hormone Dependent Neoplasms
Not applicableCompletedNorthwestern University842019-05-292022-07-05
HOrmone Therapy Immediately After Histological Diagnosis of Breast Cancer
Aromatase Inhibitors - Hormone Dependent Neoplasms, Breast Cancer Female
Phase 4UnknownCentro Hospitalar Lisboa Ocidental902018-05-012017-12-05
An Open-label Phase II Study With SUTENT in Patients Suffering From Hormone Refractory Prostate Cancer
sunitinib - Prostatic Neoplasms, Neoplasms, Hormone-Dependent
Phase 2CompletedAssistance Publique - Hôpitaux de Paris502008-03-012013-09-18
Treatment and Survival Continuation Study of Atamestane Plus Toremifene vs Letrozole in Advanced Breast Cancer
Atamestane, toremifene, letrozole - Breast Neoplasms, Neoplasms, Hormone-Dependent
Phase 3TerminatedIntarcia Therapeutics2002005-11-012007-09-10
The CAT Study: Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer
Atamestane, Toremifene, Letrozole - Breast Neoplasms, Neoplasms, Hormone-Dependent
Phase 3TerminatedIntarcia Therapeutics8422004-12-012007-08-23
Phase III Study of Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer
atamestane, toremifene, letrozole - Breast Neoplasms, Neoplasms, Hormone-dependent
Phase 3CompletedIntarcia Therapeutics8652002-06-012015-07-31

Narrower conditions

Breast Neoplasms (5)  ·  Carcinoma, Ductal, Breast (3)  ·  Carcinoma, Lobular (3)  ·  Medication Adherence (1)  ·  Prostatic Neoplasms (1)

Broader conditions

Neoplasms (7)  ·  Neoplasms by Site (6)  ·  Breast Diseases (5)  ·  Skin Diseases (5)  ·  Skin and Connective Tissue Diseases (5)  ·  Adenocarcinoma (3)  ·  Carcinoma (3)  ·  Carcinoma, Ductal (3)  ·  Neoplasms by Histologic Type (3)  ·  Neoplasms, Ductal, Lobular, and Medullary (3)  ·  Neoplasms, Glandular and Epithelial (3)  ·  Behavior (1)  ·  Genital Diseases (1)  ·  Genital Diseases, Male (1)  ·  Genital Neoplasms, Male (1)

Interventions

Aromatase Inhibitors (3)  ·  Letrozole (3)  ·  Toremifene (3)  ·  atamestane (3)  ·  Estrogen Receptor Modulators (2)  ·  Self-Management (1)  ·  Sunitinib (1)

Sponsors

Intarcia Therapeutics (3)  ·  Northwestern University (2)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  Centro Hospitalar Lisboa Ocidental (1)

Countries

United States (5)  ·  Russia (3)  ·  Ukraine (3)  ·  Canada (2)  ·  Bulgaria (1)  ·  France (1)  ·  Portugal (1)  ·  Romania (1)

Top investigators

Betina Yanez, PhD (1)  ·  Edith Perez, MD (1)  ·  Paul Goss, M.D. (1)  ·  Peter Langecker, MD, PhD (1)  ·  Vasco Fonseca, MD (1)  ·  Zacharoula Sidiropoulou (1)